Wells Fargo Adds Annexon Biosciences (ANNX) to Q4 2024 Tactical Idea List
Tweet Send to a Friend
Wells Fargo analyst Derek Archila reiterated an Overweight rating and $14.00 price target on Annexon Biosciences (NASDAQ: ANNX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
